Disulfide reduction in the endocytic pathway: Immunological functions of gamma-interferon-inducible lysosomal thiol reductase

Antioxidants and Redox Signaling

Volumn 15, Issue 3, 2011, Pages 657-668

  Hastings, Karen Taraszka ^a   Cresswell, Peter ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DIMER; DISULFIDE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANGANESE SUPEROXIDE DISMUTASE; MELANOCYTE DIFFERENTIATION ANTIGEN; OXIDOREDUCTASE; PEPTIDASE; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ACIDITY; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CYTOSOL; DISULFIDE BOND; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; ENZYME STABILITY; EUKARYOTE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LISTERIA MONOCYTOGENES; LYSOSOME; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REDUCTION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; CELL DIFFERENTIATION; DISULFIDES; ENDOCYTOSIS; ENDOSOMES; GENES, MHC CLASS II; HUMANS; MELANOCYTES; MOLECULAR SEQUENCE DATA; MONOCYTES; MURAMIDASE; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; STAT1 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; TOLL-LIKE RECEPTOR 4;

EUKARYOTA; LISTERIA MONOCYTOGENES;

EID: 79959988948     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3684     Document Type: Review

References (73)

1. Ackerman AL and Cresswell P. Cellular mechanisms gov-erning cross-presentation of exogenous antigens. Nat Im-munol 5: 678-684, 2004. (Pubitemid 39023296)
2. Amigorena S and Savina A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Im-munol 22: 109-117, 2010.
3. Arunachalam B, Phan UT, Geuze HJ, and Cresswell P. En-zymatic reduction of disulfide bonds in lysosomes: charac-terization of a gamma-interferon- inducible lysosomal thiol reductase (GILT). Proc Natl Acad SciUSA 97: 745-750, 2000. (Pubitemid 30070380)
4. Austin CD, Wen X, Gazzard L, Nelson C, Scheller RH, and Scales SJ. Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates. Proc Natl Acad SciUSA 102: 17987-17992, 2005. (Pubitemid 41798489)
5. Barjaktarevic I, Rahman A, Radoja S, Bogunovic B, Vollmer A, Vukmanovic S, and Maric M. Inhibitory role of IFN-{gamma}-inducible lysosomal thiol reductase in T cell acti-vation. J Immunol 177: 4369-4375, 2006. (Pubitemid 44469765)
6. Belicha-Villanueva A, Golding M, McEvoy S, Sarvaiya N, Cresswell P, Gollnick SO, and Bangia N. Identification of an alternate splice form of tapasin in human melanoma. Hum Immunol 71: 1018-1026, 2010.
7. Berson JF, Harper DC, Tenza D, Raposo G, and Marks MS. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell 12: 3451-3464, 2001. (Pubitemid 33108478)
8. Bogunovic B, Srinivasan P, Ueda Y, Tomita Y, and Maric M. Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS One 5: e10599,2010.
9. Bogunovic B, Stojakovic M, Chen L, and Maric M. An un-expected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase. J Biol Chem 283: 8855-8862, 2008.
10. Chang CH and Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen pre-sentation. J Exp Med 181: 765-767, 1995.
11. Collins DS, Unanue ER, and Harding CV. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 147: 4054-4059, 1991.
12. Dan WB, Ren F, Zhang C, and Zhang SQ. Molecular cloning and expression analysis of interferon-gamma-inducible-lysosomal thiol reductase gene in orange-spotted grouper, Epinephelus coioides. Fish Shellfish Immunol 23: 1315-1323, 2007. (Pubitemid 350030549)
13. Dan WB, Wang SL, Liang JQ, and Zhang SQ. Molecular cloning and expression analysis of porcine gamma-interfer-on-inducible lysosomal thiol reductase (GILT). Vet Immunol Immunopathol 126: 163-167, 2008.
14. De Zoysa M and Lee J. Molecular cloning and expression analysis of interferon-gamma inducible lysosomal thiol re-ductase (GILT)-like cDNA from disk abalone (Haliotis dis-cus discus). J Invertebr Pathol 96: 221-229, 2007. (Pubitemid 47588288)
15. Dissemond J, Goette P, Moers J, Lindeke A, Goos M, Ferrone S, and Wagner SN. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma le-sions: association with lack of spontaneous regression. Melanoma Res 13: 371-377, 2003. (Pubitemid 36900699)
16. Gainey D, Short S, and McCoy KL. Intracellular location of cysteine transport activity correlates with productive pro-cessing of antigen disulfide. J Cell Physiol 168: 248-254,1996. (Pubitemid 26308736)
17. Garcia-Borron JC and Solano F. Molecular anatomy of ty-rosinase and its related proteins: beyond the histidine-bound metal catalytic center. Pigment Cell Res 15: 162-173, 2002. (Pubitemid 34608974)
18. Giodini A and Cresswell P. Hsp90-mediated cytosolic re-folding of exogenous proteins internalized by dendritic cells. EMBO J 27: 201-211, 2008.
19. Goldstein OG, Hajiaghamohseni LM, Amria S, Sundaram K, Reddy SV, and Haque A. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immun-other 57: 1461-1470, 2008.
20. Hansen TH and Bouvier M. MHC class I antigen presenta-tion: learning from viral evasion strategies. Nat Rev Immunol 9: 503-513, 2009.
21. Haque MA, Li P, Jackson SK, Zarour HM, Hawes JW, Phan UT, Maric M, Cresswell P, and Blum JS. Absence of y-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epi-topes. J Exp Med 195: 1267-1277, 2002. (Pubitemid 34564329)
22. Harata K. X-ray structure of a monoclinic form of hen egg-white lysozyme crystallized at 313K. Comparison of two independent molecules. Acta Crystallogr D Biol Crystallogr 50: 250-257, 1994. (Pubitemid 2082181)
23. Hastings KT, Lackman RL, and Cresswell P. Functional re-quirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J Immunol 177: 8569-8577, 2006. (Pubitemid 44893819)
24. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, and Harrison SC. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313: 217-220, 2006. (Pubitemid 44066251)
25. Honey K, Duff M, Beers C, Brissette WH, Elliott EA, Peters C, Maric M, Cresswell P, and Rudensky A. Cathepsin S regulates the expression of cathepsin L and the turnover of y-interferon-inducible lysosomal thiol reductase in B lym-phocytes. J Biol Chem 276: 22573-22578, 2001.
26. Jensen PE. Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin deter-minant. J Exp Med 174: 1121-1130, 1991.
27. Jensen PE. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol 150: 3347-3356, 1993. (Pubitemid 23129712)
28. Kang HK, Mikszta JA, Deng H, Sercarz EE, Jensen PE, and Kim BS. Processing and reactivity of T cell epitopes con-taining two cysteine residues from hen egg-white lysozyme (HEL74-90). J Immunol 164: 1775-1782, 2000. (Pubitemid 30108729)
29. Lackman RL and Cresswell P. Exposure of the promonocytic cell line THP-1 to Escherichia coli induces IFN-gamma-inducible lysosomal thiol reductase expression by inflam-matory cytokines. J Immunol 177: 4833-4840, 2006. (Pubitemid 44469819)
30. Lackman RL, Jamieson AM, Griffith JM, Geuze H, and Cresswell P. Innate immune recognition triggers secretion of lysosomal enzymes by macrophages. Traffic 8: 1179-1189, 2007. (Pubitemid 47244872)
31. Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, and Garbe C. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to dis-ease activity and are predominantly directed against Mela-nA/MART1. J Invest Dermatol 116: 891-897, 2001. (Pubitemid 32554374)
32. Li P, Haque MA, and Blum JS. Role of disulfide bonds in regulating antigen processing and epitope selection. J Im-munol 169: 2444-2450, 2002. (Pubitemid 34920988)
33. Liu N, Zhang S, Liu Z, Gaowa S, and Wang Y. Character-ization and expression of gamma-interferon-inducible lyso-somal thiol reductase (GILT) gene in amphioxus Branchiostoma belcheri with implications for GILT in innate immune response. Mol Immunol 44: 2631-2637, 2007. (Pubitemid 46240324)
34. Luster AD, Weinshank RL, Feinman R, and Ravetch JV. Molecular and biochemical characterization of a novel yinterferon-inducible protein. J Biol Chem 263: 12036-12043, 1988.
35. Mandelcorn-Monson RL, Shear NH, Yau E, Sambhara S, Barber BH, Spaner D, and DeBenedette MA. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and ty-rosinase, in HLA-A2-positive vitiligo patients. J Invest Der-matol 121: 550-556, 2003. (Pubitemid 37072267)
36. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, and Cress-well P. Defective antigen processing in GILT-free mice. Sci-ence 294: 1361-1365, 2001. (Pubitemid 33063106)
37. Maric M, Barjaktarevic I, Bogunovic B, Stojakovic M, Maric C, and Vukmanovic S. Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reduc-tase expression leads to reduced T cell sensitivity and less severe autoimmunity. J Immunol 182: 746-750, 2009.
38. Mulero I, Sepulcre MP, Fuentes I, Garcia-Alcazar A, Me-seguer J, Garcia-Ayala A, and Mulero V. Vaccination of larvae of the bony fish gilthead seabream reveals a lack of correlation between lymphocyte development and adap-tive immunocompetence. Mol Immunol 45: 2981-2989, 2008.
39. Negroiu G, Dwek RA, and Petrescu SM. Folding and mat-uration of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. J Biol Chem 275: 32200-32207, 2000.
40. Nelson CA, Vidavsky I, Viner NJ, Gross ML, and Unanue ER. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 94: 628-633, 1997. (Pubitemid 27053684)
41. O'Donnell PW, Haque A, Klemsz MJ, Kaplan MH, and Blum JS. Induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells is STAT1-dependent but CIITA-independent. J Immunol 173: 731-735, 2004. (Pubitemid 38924246)
42. Ogg GS, Rod Dunbar P, Romero P, Chen JL, and Cerundolo V. High frequency of skin-homing melanocyte-specific cy-totoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188: 1203-1208, 1998. (Pubitemid 28443344)
43. Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardigo M, Borroni G, Martinetti M, Badulli C, Necker A, and Giachino C. Specific cytotoxic T lymphocyte responses against melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility com-plex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 117: 326-332, 2001. (Pubitemid 34205718)
44. Phan UT, Arunachalam B, and Cresswell P. Gamma-interferon-inducible lysosomal thiol reductase (GILT). Ma-turation, activity, and mechanism of action. J Biol Chem 275: 25907-25914, 2000.
45. Phan UT, Lackman RL, and Cresswell P. Role of the C-terminal propeptide in the activity and maturation of gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad SciUSA 99: 12298-12303, 2002.
46. Phan UT, Maric M, Dick TP, and Cresswell P. Multiple species express thiol oxidoreductases related to GILT. Im-munogenetics 53: 342-346, 2001. (Pubitemid 32678769)
47. Pisoni RL, Acker TL, Lisowski KM, Lemons RM, and Thoene JG. A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal prote-olysis. J Cell Biol 110: 327-335, 1990.
48. Pohl S, Marschner K, Storch S, and Braulke T. Glycosylation-and phosphorylation-dependent intracellular transport of lysosomal hydrolases. Biol Chem 390: 521-527, 2009.
49. Rausch MP, Irvine KR, Antony PA, Restifo NP, Cresswell P, and Hastings KT. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol 185: 2828-2835, 2010.
50. Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli JR, and Rosenberg SA. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 88: 100-108, 1996.
51. Robbins PF, El-Gamil M, Li YF, Zeng G, Dudley M, and Rosenberg SA. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J Immunol 169: 6036-6047, 2002. (Pubitemid 35291712)
52. Robila V, Ostankovitch M, Altrich-Vanlith ML, Theos AC, Drover S, Marks MS, Restifo N, and Engelhard VH. MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes. J Immunol 181: 7843-7852, 2008.
53. Rocha N and Neefjes J. MHC class II molecules on the move for successful antigen presentation. EMBO J 27: 1-5, 2008.
54. Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, and Ferrone S. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determi-nants of HLA antigens. Cancer Res 44: 3930-3935, 1984. (Pubitemid 14041618)
55. Saftig P and Klumperman J. Lysosome biogenesis and ly-sosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10: 623-635, 2009.
56. Santoro L, Reboul A, Kerblat I, Drouet C, and Colomb MG Monoclonal IgG as antigens: reduction is an early intracel-lular event of their processing by antigen-presenting cells. Int Immunol 8: 211-219, 1996. (Pubitemid 26049773)
57. Sealy R, Chaka W, Surman S, Brown SA, Cresswell P, and Hurwitz JL. Target peptide sequence within infectious hu-man immunodeficiency virus type 1 does not ensure enve-lope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase ac-tivities. Clin Vaccine Immunol 15: 713-719, 2008. (Pubitemid 351967050)
58. Seliger B, Ritz U, Abele R, Bock M, Tampe R, Sutter G, Drexler I, Huber C, and Ferrone S. Immune escape of Melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res 61: 8647-8650, 2001. (Pubitemid 34013870)
59. Shastri N, Miller A, and Sercarz EE. The expressed T cell repertoire is hierarchical: the precise focus of lysozyme-specific T cell clones is dependent upon the structure of the immunogen. J Mol Cell Immunol 1: 369-379, 1984.
60. Sigal LJ, Crotty S, Andino R, and Rock KL. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells re-quires presentation of exogenous antigen. Nature 398: 77-80, 1999.
61. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, and Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocom-patibility complex presentation of different T cell determi-nants. J Exp Med 181: 1957-1963, 1995.
62. Singh R and Cresswell P. Defective cross-presentation of viral antigens in GILT-free mice. Science 328: 1394-1398, 2010.
63. Singh R, Jamieson A, and Cresswell P. GILT is a critical host factor for Listeria monocytogenes infection. Nature 455: 1244-1247, 2008.
64. Sinnathamby G, Maric M, Cresswell P, and Eisenlohr LC. Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influ-enza hemagglutinin. J Immunol 172: 6607-6614, 2004. (Pubitemid 38669095)
65. Touloukian CE, Leitner WW, Robbins PF, Li YF, Kang X, Lapointe R, Hwu P, Rosenberg SA, and Restifo NP. Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function. Cancer Res 62: 5144-5147, 2002. (Pubitemid 35024583)
66. van Noort JM and Jacobs MJ. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules. Eur J Immunol 24: 2175-2180, 1994. (Pubitemid 24276552)
67. Vidard L, Rock KL, and Benacerraf B. The generation of immunogenic peptides can be selectively increased or de-creased by proteolytic enzyme inhibitors. J Immunol 147: 1786-1791, 1991.
68. Wang S, Bartido S, Yang G, Qin J, Moroi Y, Panageas KS, Lewis JJ, and Houghton AN. A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses. J Immunol 163: 5820-5826, 1999.
69. Wang Z, Margulies L, Hicklin DJ, and Ferrone S. Molecular and functional phenotypes of melanoma cells with abnor-malities in HLA class I antigen expression. Tissue Antigens 47: 382-390, 1996. (Pubitemid 26168343)
70. Woods IG, Wilson C, Friedlander B, Chang P, Reyes DK, Nix R, Kelly PD, Chu F, Postlethwait JH, and Talbot WS. The zebrafish gene map defines ancestral vertebrate chromo-somes. Genome Res 15: 1307-1314, 2005. (Pubitemid 41247922)
71. Zaloudik J, Moore M, Ghosh AK, Mechl Z, and Rejthar A. DNA content and MHC class II antigen expression in ma-lignant melanoma: clinical course. J Clin Pathol 41: 1078-1084, 1988.
72. Zhang D, Pan D, Cui S, Su T, Qiu L, Zhu C, and Jiang S. Molecular characterization and expression analysis of in-terferon-gamma-inducible lysosomal thiol reductase (GILT) gene from pearl oyster Pinctada fucata. Dev Comp Immunol. 34: 969-976, 2010.
73. Zheng W and Chen X. Cloning and expression analysis of interferon-gamma-inducible-lysosomal thiol reductase gene in large yellow croaker (Pseudosciaena crocea). Mol Immunol 43: 2135-2141, 2006.